The Evidence MultiStat uses the power of Biochip array technology to generate a complete patient profile of test results in less than 20 minutes, removing the need to send samples to the laboratory
The Evidence MultiStat from Randox Laboratories is designed for rapid, accurate and reliable patient diagnostic testing.
The Evidence MultiStat provides laboratory-quality test results at the point of application in less than 20 minutes.
It will be available to order later in the year.
It uses biochips to simultaneously perform up to 12 related tests in a single patient sample.
The Evidence MultiStat offers the convenience of laboratory-quality tests in a small benchtop analyser.
This machine features a touch screen user interface and Lims connectivity.
Minimal operator training is required thanks to the user-friendly software.
Obtaining results has never been quicker, or analysis easier.
Simply add the patient sample and control to the twin biochips on the reagent cartridge and slot into the analyser.
The Evidence MultiStat automatically performs the array of tests on the patient sample.
Test results are displayed in less than 20 minutes.
The Evidence MultiStat will be launched for cardiac testing and drugs of abuse screening.
The Cardiac Array comprises a multi-marker panel, including troponin, for the early assessment of myocardial infarction in accident and emergency departments.
The Cardiac Array has been shown to be 90% sensitive for myocardial infarction as early as three hours following a cardiac event.
It also offers a negative predictive value of 97% to identify patients with heart attack symptoms that have not actually had a heart attack.
The Drugs of Abuse Arrays simultaneously screen for ten Drugs of Abuse in a single sample.
The Evidence MultiStat is set to revolutionise near-patient testing through improved diagnostic information and optimised patient treatment.
